Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liuhe Dan is a traditional Chinese medicine (TCM) formula widely used in China for the treatment of inflammatory conditions such as cellulitis, acute pancreatitis, gout, and post-surgical edema. It is typically administered as an herbal ointment or oral preparation. The formula consists of multiple herbal ingredients and is believed to exert anti-inflammatory effects by modulating immune responses and reducing local tissue inflammation. Liuhe Dan has been studied for its effectiveness in reducing symptoms and hospital stays in patients with cellulitis and other inflammatory disorders[2][3][4]. Its mechanism of action involves complex interactions among its constituent herbs rather than targeting a single molecular pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on liuhe dan.